BNTX Latest Headlines

J.P. Morgan Sticks to Their Hold Rating for BioNTech SE (BNTX)

at www.tipranks.com (Tue, 27-Oct 10:27 AM)

BioNTech SE (BNTX) Receives a Buy from Canaccord Genuity

at www.tipranks.com (Tue, 27-Oct 8:37 AM)

BioNTech’s DYNASTY-Breast02 Phase 3 readout hits PFS endpoint, but companies flag “limited” benefit and higher ILD rates

Market Chameleon (Mon, 26-Oct 7:07 AM)

BioNTech says BNT113 missed progression-free survival bar, but AHEAD-MERIT continues with overall survival as the potential win condition

Market Chameleon (Tue, 13-Oct 11:14 AM)

BioNTech’s BNT113 trial misses PFS goal, but overall survival readout can still define success

Market Chameleon (Tue, 13-Oct 7:12 AM)

BioNTech Unveils First Global Data for Novel Lung Cancer Combination at WCLC 2026—What Does This Mean for Its Pipeline?

Market Chameleon (Fri, 21-Aug 11:08 AM)

BioNTech Showcases Pioneering Lung Cancer Pipeline and Unveils First-Ever Data for Novel Combination Therapy at WCLC 2026

Market Chameleon (Thu, 20-Aug 7:10 AM)

BioNTech Appoints Guido Oelkers as CEO: Strategic Shift Aims for Multi-Product Success by 2030

Market Chameleon (Mon, 3-Aug 8:40 AM)